Biodegradable scaffolds seeded with bone marrow mononuclear cells (BMCs) are the earliest
tissue-engineered vascular grafts (TEVGs) to be used clinically. These TEVGs transform …

Interferon regulatory factor 3 (IRF3) and type I interferons (IFNs) protect against infections 1
and cancer 2 , but excessive IRF3 activation and type I IFN production cause …

Macrophages populate the healthy myocardium and, depending on their phenotype, may
contribute to tissue homeostasis or disease. Their origin and role in diastolic dysfunction, a …

The development of neotissue in tissue engineered vascular grafts remains poorly understood.
Advances in mouse genetic models have been highly informative in the study of vascular …

We developed a tissue-engineered vascular graft composed of biodegradable scaffold
seeded with autologous bone marrow-derived mononuclear cells (BMMCs) that is currently in …

During aging, deterioration in cardiac structure and function leads to increased susceptibility
to heart failure. The need for interventions to combat this age-related cardiac decline is …

Objective: To evaluate the growth potential of a tissue-engineered vascular graft (TEVG) in
a juvenile animal model. Methods: Polyglycolic acid nonwoven mesh tubes (3-cm length, 1.3-…

Activin type II receptor (ActRII) ligands have been implicated in muscle wasting in aging and
disease. However, the role of these ligands and ActRII signaling in the heart remains unclear…

Bone marrow stromal cells (MSCs) are a promising cell source for a variety of tissue engineering
applications, given their ready availability and ability to differentiate into multiple cell …

Heart failure with preserved ejection fraction (HFpEF) is the most common type of HF in older
adults. Although no pharmacological therapy has yet improved survival in HFpEF, exercise …